FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to immunology. What is presented is a composition containing at least two antibodies which bind different epitopes of human EGFR (ErbB-1) thereby providing a synergetic effect; what is also presented is a bi-specific molecule representing an antibody or a fragment thereof containing sequences of CDR antibodies as a part of the composition according to the invention. What is considered is the use of the composition according to the invention for preparing a drug and a pharmaceutical composition containing the composition according to the invention.
EFFECT: composition according to the present invention provides a synergetic effect of anti-EGFR antibodies that can find further application in treating cancer.
20 cl, 17 tbl, 21 ex, 42 dwg
Title | Year | Author | Number |
---|---|---|---|
COMPOSITIONS OF RECOMBINANT ANTIBODIES FROM EPIDERMAL GROWTH FACTOR RECEPTOR | 2009 |
|
RU2540146C2 |
EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY | 2013 |
|
RU2652880C2 |
ANTI-IDIOTYPICAL ANTIBODIES THAT INDUCE IMMUNE RESPONSE AGAINST EPIDERMAL GROWTH FACTOR RECEPTOR | 1996 |
|
RU2172636C2 |
SPECIFIC BINDING PROTEINS AND APPLICATIONS THEREOF | 2010 |
|
RU2549678C2 |
SPECIFIC BINDING PROTEINS AND APPLICATIONS THEREOF | 2010 |
|
RU2673724C2 |
BISPECIFIC BINDING AGENTS WITH INTERSPECIFIC SPECIFICITY | 2008 |
|
RU2535992C2 |
HUMAN ANTIBODIES TO RECEPTOR OF EPIDERMAL GROWTH FACTOR | 2005 |
|
RU2402569C2 |
ANTIBODIES-ANTAGONISTS AGAINST Notch3 AND THEIR APPLICATION FOR PREVENTION AND TREATMENT OF Notch3-RELATED DISEASES | 2007 |
|
RU2493167C2 |
BISPECIFIC ANTIGEN-BINDING PROTEIN EGFR/CD16 | 2019 |
|
RU2792240C2 |
BINDING MOLECULE SPECIFIC FOR HER3, AND THEIR APPLICATIONS | 2012 |
|
RU2620068C2 |
Authors
Dates
2013-07-27—Published
2008-02-27—Filed